Key facts
- AstraZeneca opened a new research and development center in Cambridge, Massachusetts.
- The investment in Massachusetts exceeds $1 billion.
- The expansion aims to grow research operations and the workforce.
AstraZeneca opened a new research and development center in Cambridge, Massachusetts, on Monday as part of an investment exceeding $1 billion in the state. The move is intended to expand the company's research operations and workforce.
The company's investment in the U.S. is part of a larger plan, with AstraZeneca announcing plans to invest $50 billion in America for medicines.